Gemme Bemoans ‘State Of Emergency’ In France
French Generics See Weak Growth And Biosimilars Need A Boost
French off-patent industry association Gemme has declared a “state of emergency” for French generics as it revealed industry data for 2019 pointing to weak growth. Meanwhile, Gemme says, the country’s biosimilars market is “dynamic” and growing quickly but is still under-performing.
